BPMC - Blueprint Medicines Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 54.88B
Enterprise Value 34.46B
Trailing P/E N/A
Forward P/E 1-12.52
PEG Ratio (5 yr expected) 1-0.37
Price/Sales (ttm)110.07
Price/Book (mrq)12.81
Enterprise Value/Revenue 3100.67
Enterprise Value/EBITDA 6-16.36

Trading Information

Stock Price History

Beta (3Y Monthly) 1.48
52-Week Change 360.96%
S&P500 52-Week Change 36.04%
52 Week High 3101.91
52 Week Low 344.58
50-Day Moving Average 392.47
200-Day Moving Average 380.33

Share Statistics

Avg Vol (3 month) 3478.04k
Avg Vol (10 day) 3267.22k
Shares Outstanding 543.84M
Float 48.19M
% Held by Insiders 11.45%
% Held by Institutions 195.00%
Shares Short (Jun 28, 2019) 42.47M
Short Ratio (Jun 28, 2019) 43.95
Short % of Float (Jun 28, 2019) 46.65%
Short % of Shares Outstanding (Jun 28, 2019) 45.06%
Shares Short (prior month May 31, 2019) 42.34M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin 0.00%
Operating Margin (ttm)-628.01%

Management Effectiveness

Return on Assets (ttm)-28.76%
Return on Equity (ttm)-58.46%

Income Statement

Revenue (ttm)44.3M
Revenue Per Share (ttm)1.01
Quarterly Revenue Growth (yoy)-23.50%
Gross Profit (ttm)-199.1M
EBITDA -272.5M
Net Income Avi to Common (ttm)-267.5M
Diluted EPS (ttm)-6.08
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)415.86M
Total Cash Per Share (mrq)8.51
Total Debt (mrq)99.6M
Total Debt/Equity (mrq)28.94
Current Ratio (mrq)6.59
Book Value Per Share (mrq)7.79

Cash Flow Statement

Operating Cash Flow (ttm)-205.63M
Levered Free Cash Flow (ttm)-122.76M